I am an Assistant Professor in the Department of Surgical Oncology at MD Anderson Cancer Center, where I strive to provide the best contemporary multidisciplinary care for my patients with soft tissue sarcoma (STS) and cutaneous malignancies. My research is focused on improving sarcoma patient outcomes by elucidating the role of the epigenome in STS and investigating the role of immunotherapy for patients with STS. I have a broad background in chemistry and cancer biology, with specific training in cancer epigenomics, immuno-oncology, and the design and implementation of neoadjuvant clinical trials. I have long nurtured a passion for experimental research from my undergraduate days in synthetic and medicinal chemistry, obtaining degrees in Biochemical Sciences and Chemistry and Chemical Biology, and working to develop cancer therapeutics at Infinity Pharmaceuticals. After completing my medical degree, I entered surgical residency at Brigham and Women’s Hospital during which I had the opportunity to pursue a basic science research fellowship from 2012-2014 at MD Anderson Cancer Center in the Department of Genomic Medicine and where I gained expertise in chromatin biology and cancer epigenomics. Upon completion of my surgical residency in 2016, I returned to MD Anderson to pursue subspecialty surgical training in Surgical Oncology. During my fellowship training, I continued my work in cancer epigenetics and developed expertise in immunotherapy for melanoma and STS. I additionally gained experience in developing and implementing clinical trials and conducting associated translational and collaborative studies. I formed diverse and productive collaborative relationships during my training at MD Anderson, successfully collaborating with and bridging the gap between scientists and clinicians across disciplines, including bioinformaticians, computational biologists, molecular and cellular biology basic scientists, pathologists, and surgical oncologists both within the institution, nationally, and internationally. As a surgeon-scientist, I am well positioned to identify gaps in medical knowledge and patient needs and will address these clinically relevant research questions through clinical and translational research efforts and collaborations.